Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination.
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic genes in vivo. Whereas in many organs an antiviral T cell response eliminates the vector and damages local tissue, when adenovirus vectors are injected into the brain the subsequent immune attack can be ineffective, allowing the vector to persist. In the present study, E1-deleted human adenovirus vectors were injected into the caudate nucleus of rats. Two months later, expression of protein from the vector was still evident and little inflammation was seen. A subcutaneous injection of adenovirus vector at this time, however, led within 2 weeks to severe mononuclear inflammation and microglial activation in the caudate. This caused local demyelination and a decrease in detectable protein expression from the vector. Interestingly, intense microglial activation and numerous lymphocytes and monocytes were also seen in brain areas containing neurons capable of retrogradely transporting the adenovirus vector from the caudate. Control experiments established that this inflammation in distant brain areas was not a nonspecific consequence of degeneration. These experiments demonstrate that although adenovirus vectors can persist in the brain without causing chronic inflammation, they remain the potential target of a damaging cell-mediated immune response brought about by a subsequent peripheral exposure to vector. The finding of lymphocytes in brain areas that project to the caudate further shows that viral antigens that are retrogradely transported by neurons can also be the target of a T cell attack.
Byrnes
A P
AP
Department of Human Anatomy, University of Oxford, United Kingdom.
MacLaren
R E
RE
Charlton
H M
HM
D000256:Adenoviridae / Q000235:genetics*; D000344:Afferent Pathways / Q000473:pathology; D000818:Animals; D000917:Antibody Formation; D001921:Brain / Q000473:pathology / Q000503:physiopathology / Q000821:virology*; D003711:Demyelinating Diseases / Q000473:pathology / Q000503:physiopathology / Q000821:virology*; D015536:Down-Regulation; D004660:Encephalitis / Q000473:pathology / Q000503:physiopathology / Q000821:virology*; D005805:Genes, MHC Class I / Q000502:physiology; D005802:Genes, MHC Class II / Q000502:physiology; D005822:Genetic Vectors / Q000276:immunology*; D051381:Rats; D011919:Rats, Inbred Strains; D001616:beta-Galactosidase / Q000378:metabolism
D001616:beta-Galactosidase